Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

PDL BioPharma Inc (NASDAQ:PDLI)

2.22
Delayed Data
As of 4:00pm ET
 -0.05 / -2.20%
Today’s Change
1.93
Today|||52-Week Range
3.84
+4.72%
Year-to-Date
8 High-Yield Stocks With Falling Prices
6:00pm / GuruFocus News - Paid Partner Content
 

Today’s Trading

Previous close2.27
Today’s open2.31
Day’s range2.21 - 2.31
Volume1,440,162
Average volume (3 months)2,341,750
Market cap$375.8M
Dividend yield8.82%
Data as of 4:00pm ET, 02/21/2017

Growth & Valuation

Earnings growth (last year)+9.14%
Earnings growth (this year)-74.34%
Earnings growth (next 5 years)+17.00%
Revenue growth (last year)+0.01%
P/E ratio2.1
Price/Sales0.99
Price/Book0.53

Competitors

 Today’s
change
Today’s
% change
CRISCuris Inc-0.02-0.75%
BLCMBellicum Pharmaceuti...-0.23-1.69%
MCRBSeres Therapeutics I...-0.01-0.10%
BOLDAudentes Therapeutic...-0.15-0.90%
Data as of 4:00pm ET, 02/21/2017

Financials

Next reporting dateMarch 6, 2017
EPS forecast (this quarter)$0.09
Annual revenue (last year)$585.1M
Annual profit (last year)$332.8M
Net profit margin56.88%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John Peter McLaughlin
Chief Financial Officer &
Vice President
Peter S. Garcia
Corporate headquarters
Incline Village, Nevada

Forecasts


Search for Jobs